SUMMARY
NAD+ levels do not significantly increase in humans despite the effectiveness of precursors like NMN (Nicotinamide Mononucleotide) and NR (Nicotinamide Riboside) in mice. Research indicates that various strategies to boost NAD+ levels have shown positive outcomes in preclinical settings, yet translating these findings to humans remains challenging. The review by Katsyuba et al. (2020) highlights the complexities of NAD+ biochemistry and metabolism, emphasizing the need for further exploration into effective NAD+ boosters for enhancing healthspan and lifespan.
PREREQUISITES
- NAD+ biochemistry
- Understanding of NMN and NR as NAD+ precursors
- Knowledge of metabolic pathways affecting NAD+ levels
- Familiarity with healthspan and lifespan research
NEXT STEPS
- Research the mechanisms of NAD+ metabolism in humans
- Explore clinical trials involving NMN and NR supplementation
- Investigate the role of NAD+ in age-related diseases
- Learn about current and emerging NAD+ boosters on the market
USEFUL FOR
Researchers, healthcare professionals, and individuals interested in the implications of NAD+ levels on health and aging will benefit from this discussion.